Black Friday Sale! Save huge on InvestingProGet up to 60% off

Premarket analyst action - healthcare

Published 12/14/2017, 08:43 AM
© Reuters.  Premarket analyst action - healthcare
GS
-
JPM
-
THC
-
ARQL
-
BMRN
-
CYH
-
GWPH
-
ESPR
-
ONCE_old
-
  • ArQule (NASDAQ:ARQL) upgraded to Buy with a $5 (285% upside) price target by Needham.
  • BioMarin Pharmaceutical (NASDAQ:BMRN) upgraded to Outperform with a $110 (26% upside) price target by Wedbush.
  • Esperion Therapeutics (NASDAQ:ESPR) upgraded to Strong Buy with an $81 (42% upside) price target by Needham.
  • GW Pharmaceuticals (NASDAQ:GWPH) upgraded to Buy with a $174 (40% upside) price target by Goldman Sachs (NYSE:GS).
  • Community Health Systems (NYSE:CYH) downgraded to Underweight by JPMorgan (NYSE:JPM) with no price target citing no benefit from tax reform, high degree balance sheet leverage and structural changes in the hospital sector.
  • Spark Therapeutics (NASDAQ:ONCE) downgraded to Neutral with a $58 (26% upside) price target by Goldman Sachs.
  • Tenet Healthcare (NYSE:THC) downgraded to Underweight by JPMorgan with a $15 (flat) price target for the same reasons cited for CYH.
  • Now read: BioMarin, Spark, And Insertional Oncogenesis


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.